BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keikha M, Karbalaei M. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis. New Microbes New Infect 2021;41:100865. [PMID: 33912350 DOI: 10.1016/j.nmni.2021.100865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Keikha M, Kamali H. The impact of Saccharomyces boulardii adjuvant supplementation on alternation of gut microbiota after H. pylori eradication; a metagenomics analysis. Gene Reports 2022;26:101499. [DOI: 10.1016/j.genrep.2022.101499] [Reference Citation Analysis]
2 Askari P, Karbalaei M, Ghazvini K, Keikha M. Severe clinical outcomes of infection with babA2-positive Helicobacter pylori strains in the Iranian population: A systematic review and meta-analysis. Meta Gene 2021;29:100911. [DOI: 10.1016/j.mgene.2021.100911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
3 Brasil-costa I, Souza CDO, Monteiro LCR, Santos MES, Oliveira EHCD, Burbano RMR. H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil. Pathogens 2022;11:414. [DOI: 10.3390/pathogens11040414] [Reference Citation Analysis]
4 Liang H, Lin S, Ji Y, Xiao Y, Zheng G. Helicobacter pylori increases the risk of carotid plaque formation: a clinical evidence. Ann Med 2021;53:1448-54. [PMID: 34431440 DOI: 10.1080/07853890.2021.1927169] [Reference Citation Analysis]
5 Keikha M, Karbalaei M. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterol 2021;21:388. [PMID: 34670526 DOI: 10.1186/s12876-021-01977-1] [Reference Citation Analysis]